Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.4 USD | +1.48% | +4.75% | +41.81% |
28/06 | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
28/06 | NOVO NORDISK : UBS gives a Neutral rating | ZD |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- NOVO B Stock
- NONOF Stock
- Revisions Novo Nordisk A/S